Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[High-dose buprenorphine substitution during incarceration.]

Catherine Reynaud-Maurupt1, Yves Caer, Noëlle Escaffre

  • 1Groupe de recherche sur la vulnérabilité sociale, Tourrette-Levens (06).

Presse Medicale (Paris, France : 1983)
|May 24, 2005
PubMed
Summary

This study examined opiate addicts in French prisons. High-dose buprenorphine substitution therapy did not show a clear impact on health or incarceration, but treated patients had different profiles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same author

Brown adipose tissue activity impacts systemic lactate clearance in male mice.

The Journal of physiology·2025
Same author

Remodeling of RNA-binding proteome and RNA-mediated regulation as a new layer of control of sporulation.

mSystems·2025
Same author

RagB stimulates the activity of the peptidoglycan polymerase RodA in Bacillus subtilis.

EMBO reports·2025
Same author

Is blood vitamin B6 a marker of interest for individualized psoriasis disease care management in cardiovascular disease prevention?

Clinical nutrition (Edinburgh, Scotland)·2025
Same author

Plateforme Contrôle Qualité Périnat IDF.

Journal of epidemiology and population health·2025

Area of Science:

  • Addiction Medicine
  • Criminology
  • Public Health

Background:

  • Opiate addiction is a significant public health issue with complex social and medical dimensions.
  • Incarcerated individuals with opiate addiction present unique challenges for treatment and management.
  • Substitution therapy is a key component in managing opiate addiction.

Purpose of the Study:

  • To characterize the social and medical profiles of incarcerated opiate addicts.
  • To evaluate the impact of high-dose buprenorphine substitution therapy on prisoner health and incarceration.
  • To compare outcomes between prisoners receiving and not receiving substitution treatment upon arrival.

Main Methods:

  • A prospective survey of opiate addicts was conducted in 6 French prison centers.

Related Experiment Videos

  • Data was collected at admission and after 2 months of incarceration (December 2001 - February 2003).
  • Participants included individuals already on substitution treatment and those undergoing withdrawal.

    • Main Results:

    • No significant difference in incarceration course was observed between groups, except for medical follow-up.
    • Prisoners receiving substitution treatment had less stable occupational histories and more severe addiction/incarceration histories.
    • Buprenorphine patients reported more intensive pre-incarceration medical follow-up.

    Conclusions:

    • The impact of buprenorphine substitution therapy during incarceration was not definitively demonstrated in this study.
    • Prisoners receiving buprenorphine treatment exhibited distinct social and medical profiles compared to untreated individuals.
    • Further research is needed to understand the role of substitution therapy in the incarcerated opiate-addicted population.